Clinical Trials List
Protocol NumberCP-MGAH22-06
Completed
2019-10-15 - 2024-05-28
Phase II/III
Terminated1
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ying-Chun Shen Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
82 participants
